Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Cannell Capital Increases Exposure to Small-Caps with Health Insurance Innovations Inc (HIIQ)

Page 1 of 2

J. Carlo Cannell’s Cannell Capital has disclosed a new position in Health Insurance Innovations Inc (NASDAQ:HIIQ) in a recent Form 3 filing. The firm reported indirect investments in Health Insurance Innovations Inc (NASDAQ:HIIQ) with 533,948 class A common shares through Tristan Partners, L.P and 255,387 class A shares through Tristan Offshore Fund, Ltd. This is not the only small cap stock in Cannell’s portfolio as it also initiated new stakes in Genesis Healthcare Inc (NYSE:GEN), Jive Software Inc (NASDAQ:JIVE), Ring Energy Inc (NYSEMKT:REI) during the first quarter of 2015.

J. Carlo Cannell established the fund in 1992 with his personal investment of $600,000. The investment manager targets primarily small-cap companies with a value-oriented and neutral approach with respect to the market. Cannell Capital boasts an equity portfolio of $319.86 million, as reported in its latest 13F filing with the SEC. The major investment areas of the fund manager include information technology followed by consumer discretionary and utilities & communication sector.

Carlo Cannell

Let’s first take a step back and analyze how tracking hedge funds can help an everyday investor. Through our research, we discovered that a portfolio of the 15 most popular small-cap picks of hedge funds beat the S&P 500 Total Return Index by nearly a percentage point per month on average between 1999 and 2012. On the other hand the most popular large-cap picks of hedge funds underperformed the same index by seven basis points per month during the same period. This is likely a surprise to many investors, who think of small-caps as risky, unpredictable stocks and put more faith in large-cap stocks. In forward tests since August 2012 these top small-cap stocks beat the market by an impressive 84 percentage points, returning over 144% (read the details here). Hence a retail investor needs to isolate himself from the herd and take advantage of the best growth opportunities in the market by concentrating on small-cap stocks.

Recently, the founder of Health Insurance Innovations Inc (NASDAQ:HIIQ) a Tampa-base health insurance seller, Michael Kosloske, has stepped down from the position of President leaving the chair in the hands of Patrick McNamee. Among analysts, the stock of Health Insurance Innovations Inc (NASDAQ:HIIQ) has received an average “Buy” rating with one year average price target of $8.17 indicating an upside of more than 60% from its current share prices. Joe Huber‘s Huber Capital Management and Jacob Gottlieb’s Visium Asset Management are among the major shareholders of Health Insurance Innovations Inc (NASDAQ:HIIQ).

J. Carlo Cannell
J. Carlo Cannell
Cannell Capital

In its 13F filing for the reporting period ended March 31, 2015, Cannell reported a new position in Genesis Healthcare Inc (NYSE:GEN) with 1.49 million shares valued at $10.58 million. Genesis is a healthcare group, which has recently announced the acquisition of 24 nursing facilities of Revera Inc. for $240 million along with the contract rehabilitation business of the latter. The deal involves the real estate of 20 of these facilities and a long-term lease agreement with Health Care REIT, Inc. (NYSE:HCN) for the remaining four facilities. This transaction will help Genesis Healthcare Inc (NYSE:GEN) maintain a strong foot in its primary markets including Northeast, Washington, and New Jersey. The stock ot the post-acute care provider company has lost 24.12% year-to-date and it has market cap of $1.03 billion.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!